Mathias Bressel

5.9k total citations · 2 hit papers
184 papers, 3.8k citations indexed

About

Mathias Bressel is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Mathias Bressel has authored 184 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Pulmonary and Respiratory Medicine, 68 papers in Oncology and 59 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Mathias Bressel's work include Advanced Radiotherapy Techniques (37 papers), Medical Imaging Techniques and Applications (30 papers) and Lung Cancer Diagnosis and Treatment (30 papers). Mathias Bressel is often cited by papers focused on Advanced Radiotherapy Techniques (37 papers), Medical Imaging Techniques and Applications (30 papers) and Lung Cancer Diagnosis and Treatment (30 papers). Mathias Bressel collaborates with scholars based in Australia, New Zealand and United States. Mathias Bressel's co-authors include Tomas Kron, Farshad Foroudi, Shankar Siva, Rodney J. Hicks, Declan G. Murphy, Michael S. Hofman, David Ball, Suki Gill, Daniel Pham and Alexander G. Heriot and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Mathias Bressel

172 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ibrutinib plus Venetoclax for the Treatment of Mantle-Cell Lymphoma

2018 274 citations Constantine S. Tam, Mary Ann Anderson et al. profile →
Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

2018 222 citations Shankar Siva, Mathias Bressel et al. profile →

Peers

Countries citing papers authored by Mathias Bressel

Since Specialization

Citations

This map shows the geographic impact of Mathias Bressel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Bressel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Bressel more than expected).

Fields of papers citing papers by Mathias Bressel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Bressel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Bressel. The network helps show where Mathias Bressel may publish in the future.

Co-authorship network of co-authors of Mathias Bressel

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Bressel. A scholar is included among the top collaborators of Mathias Bressel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Bressel. Mathias Bressel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of the R.E.N.A.L. complexity score on outcomes of stereotactic ablative body radiotherapy for primary renal cell carcinoma 2025 ·British Journal of Urology ·Muhammad Shaiq Ali, Mathias Bressel, (unknown), (unknown), (unknown), (unknown), Declan G. Murphy, Renu Eapen, Marlon Perera, Nathan Lawrentschuk, Arun Azad, Sarat Chander, (unknown), Nicholas Hardcastle, Shankar Siva	0
2	Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma 2025 ·Blood Advances ·Sasanka M. Handunnetti, Amit Khot, Piers Blombery, Kate Burbury, Philip A. Thompson, David Ritchie, Rodney J. Hicks, (unknown), Rachel Koldej, Mathias Bressel, (unknown), David Westerman, Stephen Lade, Andrew W. Roberts, John F. Seymour, Constantine S. Tam, Mary Ann Anderson	0
3	Prognostic Subgroups for Disease-Free Survival With Cutaneous Squamous Cell Carcinoma of the Head and Neck 2025 ·JAMA Otolaryngology–Head & Neck Surgery ·Sandro Porceddu, Emma Connolly, Mathias Bressel, Chris Wratten, Howard Liu, Danny Rischin	0
4	Beacon: A phase II study of bevacizumab, atezolizumab, and cobimetinib in patients with recurrent, platinum resistant, high grade serous ovarian cancer. 2024 ·Journal of Clinical Oncology ·(unknown), Mathias Bressel, (unknown), Yi-An Ko, Anne Hamilton, Clare L. Scott, Linda Mileshkin, (unknown), (unknown), Sumitra Ananda, Jayesh Desai, Danny Rischin, Paul J. Neeson, David D.L. Bowtell, George Au‐Yeung, (unknown)	1
5	Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions 2024 ·Blood ·Sasanka M. Handunnetti, Mary Ann Anderson, Kate Burbury, Philip A. Thompson, (unknown), Mathias Bressel, (unknown), Rodney J. Hicks, David Westerman, Stephen Lade, Christiane Pott, Rishu Agarwal, Rachel Koldej, David Ritchie, Martin Dreyling, Mark A. Dawson, Sarah‐Jane Dawson, John F. Seymour, Andrew W. Roberts, Constantine S. Tam	7
6	TROG 15.03/ANZUP International Multicenter Phase II Trial of Focal Ablative STereotactic RAdiotherapy for Cancers of the Kidney (FASTRACK II) 2023 ·International Journal of Radiation OncologyBiologyPhysics ·Shankar Siva, Mathias Bressel, Mark Sidhom, Swetha Sridharan, Ben Vanneste, Ronald B. Davey, Jeremy Ruben, Farshad Foroudi, Braden Higgs, (unknown), A. Raman, Nicholas Hardcastle, Mark Shaw, (unknown), Nathan Lawrentschuk, Simon N. Wood, Nicholas R. Brook, Tomas Kron, Jarad Martin, David Pryor	6
7	PO003/#269 Ignite: a phase II signal-seeking trial of adavosertib targeting recurrent high grade serous ovarian cancer with cyclin E1 over-expression with and without gene amplification 2023 ·George Au‐Yeung, Mathias Bressel, Owen W.J. Prall, (unknown), John Andrews, (unknown), Yeh Chen Lee, Bo Gao, Tarek Meniawy, Sally Baron‐Hay, (unknown), Ganessan Kichenadasse, Sumitra Ananda, Peter T. Fox, David D.L. Bowtell, Linda Mileshkin	2
8	Are dynamic or fixed FDG‐PET measures of disease of greater prognostic value in patients with relapsed/refractory diffuse large B‐cell lymphoma undergoing autologous haematopoietic stem cell transplantation? 2023 ·British Journal of Haematology ·Belinda A. Campbell, (unknown), Alessandro Lambertini, Michael S. Hofman, Mathias Bressel, John F. Seymour, Andrew Wirth, Michael MacManus, Michael Dickinson	2
9	Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre 2023 ·BMC Cancer ·Annie Wang, (unknown), (unknown), (unknown), Mathias Bressel, Andrew Hui, (unknown), David L. Kok	5
10	PEMBROLIZUMAB AS FIRST THERAPY FOR HODGKIN LYMPHOMA IS DELIVERABLE IN OLDER OR ABVD‐INELIGIBLE PATIENTS, ALLOWS SUBSEQUENT THERAPY, AND GIVES ADEQUATE SURVIVAL. 2023 ·Hematological Oncology ·Michael Dickinson, Judith Trotman, Leanne Berkahn, Jason Butler, Mathias Bressel, Paul J. Neeson, Adrian Minson	6
11	Nodal metabolic tumour volume on baseline ¹⁸F‐FDG PET/CT and overall survival in stage II and III NSCLC patients undergoing curative‐intent chemoradiotherapy/radiotherapy 2021 ·Journal of Medical Imaging and Radiation Oncology ·Ramin Alipour, (unknown), Mathias Bressel, Sarah Everitt, Michael MacManus, Shankar Siva, Michael S. Hofman, Tim Akhurst, Rodney J. Hicks, Amir Iravani	2
12	UpFrontPSMA: a randomized phase 2 study of sequential ¹⁷⁷ Lu‐PSMA‐617 and docetaxel vs docetaxel in metastatic hormone‐naïve prostate cancer (clinical trial protocol) 2021 ·British Journal of Urology ·Nattakorn Dhiantravan, Louise Emmett, Anthony M. Joshua, David A. Pattison, Roslyn J. Francis, Scott Williams, Shahneen Sandhu, Ian D. Davis, Ian Vela, (unknown), Mathias Bressel, Declan G. Murphy, Michael S. Hofman, Arun Azad	40
13	A phase I/II study of stereotactic radiotherapy and pembrolizumab for oligometastatic renal tumours (RAPPORT): Clinical trial protocol 2021 ·Contemporary Clinical Trials Communications ·David Pryor, Mathias Bressel, Nathan Lawrentschuk, Ben Tran, Jennifer Mooi, Jeremy Lewin, Arun Azad, (unknown), (unknown), Mark Shaw, Sarat Chander, Paul J. Neeson, Daniel Moon, Katharine Cuff, Simon Wood, Declan G. Murphy, Shahneen Sandhu, Sherene Loi, Shankar Siva	7
14	Results of phase II trial of intensified neoadjuvant treatment with interdigitating radiotherapy and chemotherapy with oxaliplatin, 5-fluorouracil and folinic acid in patients with locally advanced rectal cancer (PROARCT trial) 2020 ·Radiotherapy and Oncology ·Sweet Ping Ng, Julie Chu, Sarat Chander, Mathias Bressel, Joseph McKendrick, Rachel Wong, Malcolm Steel, William K. Murray, Trevor Leong, Alexander G. Heriot, Michael Michael, Samuel Y. Ngan	6
15	Prognostic Significance of PD-L1+ and CD8+ Immune Cells in HPV+ Oropharyngeal Squamous Cell Carcinoma 2018 ·Cancer Immunology Research ·Benjamin Solomon, Richard J. Young, Mathias Bressel, Damien Urban, Shona Hendry, Alesha A. Thai, Christopher Angel, (unknown), Marcin Kowanetz, Tsien Fua, June Corry, Stephen B. Fox, Danny Rischin	100
16	The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing 2018 ·JMIR Formative Research ·(unknown), Ian Collins, Mathias Bressel, Phyllis Butow, Jon Emery, Louise Keogh, Prue C. Weideman, (unknown), John L. Hopper, Alison H. Trainer, G. Bruce Mann, Adrian Bickerstaffe, Antonis C. Antoniou, Jack Cuzick, Kelly‐Anne Phillips	13
17	iPrevent®: a tailored, web-based, decision support tool for breast cancer risk assessment and management 2016 ·Breast Cancer Research and Treatment ·Ian Collins, Adrian Bickerstaffe, (unknown), (unknown), Louise Keogh, Jon Emery, G. Bruce Mann, Phyllis Butow, Prue C. Weideman, (unknown), Alison H. Trainer, Mathias Bressel, John L. Hopper, Jack Cuzick, Antonis C. Antoniou, Kelly‐Anne Phillips	26
18	The outcome of a multi-centre feasibility study of online adaptive radiotherapy for muscle-invasive bladder cancer TROG 10.01 BOLART 2014 ·Radiotherapy and Oncology ·Farshad Foroudi, Daniel Pham, Aldo Rolfo, Mathias Bressel, Colin Tang, (unknown), Sandra Turner, George Hruby, Stephen B. Williams, Dickon Hayne, Margot Lehman, Marketa Skala, Chakiath Jose, (unknown), Tomas Kron	37
19	Practical implementation of an existing smoking detection pipeline and reduced support vector machine training corpus requirements 2013 ·Journal of the American Medical Informatics Association ·Richard Khor, (unknown), Mathias Bressel, (unknown), Gillian Duchesne, Farshad Foroudi	13
20	[Determination of steroid receptors in prostate cancer: possibilities and limits]. 1986 ·PubMed ·(unknown), Michael Krieg, H Klosterhalfen, Mathias Bressel, (unknown)	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact